|
Cardiovascular Intervention
Citations 141-150 of 451 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Analysis of Observational Studies in the Presence of Treatment Selection Bias: Effects of Invasive Cardiac Management on AMI Survival Using Propensity Score and Instrumental Variable Methods
- Thérèse A. Stukel; Elliott S. Fisher; David E. Wennberg; David A. Alter; Daniel J. Gottlieb; Marian J. Vermeulen
JAMA 2007; 297: 278-285.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
Death Not Necessarily End for Heart Devices
- Mike Mitka
JAMA 2007; 297: 144-145.
[Extract]
[Full text]
[PDF]
- Original Contributions
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
- Eric L. Eisenstein; Kevin J. Anstrom; David F. Kong; Linda K. Shaw; Robert H. Tuttle; Daniel B. Mark; Judith M. Kramer; Robert A. Harrington; David B. Matchar; David E. Kandzari; Eric D. Peterson; Kevin A. Schulman; Robert M. Califf
JAMA 2007; 297: 159-168.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial
- The APEX AMI Investigators
JAMA 2007; 297: 43-51.
[Abstract]
[Full text]
[PDF]
- Editorials
Pexelizumab Does Not "Complement" Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction
- John W. Eikelboom; Martin ODonnell
JAMA 2007; 297: 91-92.
[Extract]
[Full text]
[PDF]
- Clinical Reviews
Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock
- Anil K. Gehi; Davendra Mehta; J. Anthony Gomes
JAMA 2006; 296: 2839-2847.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
Flawed Prescribing Practices Revealed
- Tracy Hampton
JAMA 2006; 296: 2191-2192.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Critics Say Drug-Eluting Stents Overused
- Mike Mitka
JAMA 2006; 296: 2077.
[Extract]
[Full text]
[PDF]
- Research Letters
Clinical Consequences of Generic Warfarin Substitution: An Ecological Study
- J. Michael Paterson; Muhammad Mamdani; David N. Juurlink; Gary Naglie; Andreas Laupacis; Thérèse A. Stukel
JAMA 2006; 296: 1969-a-1972-a.
[Extract]
[Full text]
[PDF]
- From the Centers for Disease Control and Prevention
Update: Delayed Onset Pseudomonas fluorescens Bloodstream Infections After Exposure to Contaminated Heparin FlushMichigan and South Dakota, 2005-2006
-
JAMA 2006; 296: 1831-1833.
[Extract]
[Full text]
[PDF]
|
|